Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–76
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who complete 26-week maintenance treatment of the A3921084 study or subjects who withdraw early due to A3921084 study treatment failure (see Appendix 5).
Women of childbearing potential must test negative for pregnancy prior to study enrolment.
Sexually active females of childbearing potential are required to use adequate contraceptive methods during the study period and until completion of the follow-up procedures. No specific contraceptive measures are required in male subjects during study participation.
You may not be if
Subjects who have been discontinued due to protocol violation(s) (as determined by the Sponsor) in the A3921084 study.
Subjects who were discontinued from the A3921084 study due to an adverse event.
Subjects likely to require any non-elective surgery or surgery requiring overnight stay (with the exception of minor same day outpatient procedures that will not interfere with study drug dosing).
